4020S1 9

Download
Share  Add to  Flag Embed
Uploaded from authorPOINTLite
Views:
 
Category: Entertainment
     
 
License:   All Rights Reserved

Presentation Description

No description available.

Comments

Presentation Transcript

Influenza Vaccine Responses : 

Influenza Vaccine Responses Roland A. Levandowski, M.D. Division of Viral Products Prepared for Vaccines and Related Biological Products Advisory Committee 18-19 February 2004

Slide2: 

    1. ALAN HAMPSON ADULT A/NEW CALEDONIA/20/99-LIKE (H1N1) WHO, AUSTRALIA ELDER A/PANAMA/2007/99 (H3N2) B/SHANGDONG/07/97   2. JOHN WOOD, PH.D ADULT A/NEW CALEDONIA/20/99 (H1N1) NIBSC, ENGLAND ELDER A/PANAMA/2007/99 (H3N2) B/SHANGDONG/7/97   3. TAKATO ODIGARI, PH.D. ADULT A/NEW CALEDONIA/20/99-LIKE (H1N1) WHO, JAPAN ELDER A/PANAMA/2007/99-LIKE (H3N2) B/HONG KONG/330/01-LIKE   Serum Panels for Serologies

Slide3: 

Serum Panels for Serologies     4. STEFAN GRAVENSTEIN, M.D. ADULT A/NEW CALEDONIA/20/99 (H1N1) EASTERN VIRGINIA ELDER A/PANAMA/2007/99 (H3N2) MEDICAL SCHOOL CHILD B/HONG KONG/1434/2002   5. CHRISTINE TURLEY, M.D. CHILD A/NEW CALEDONIA/20/99 (H1N1) UTMB A/PANAMA/2007/99 (H3N2) GALVESTON, TEXAS B/HONG KONG/1434/2002  6. STEFAN GRAVENSTEIN, M.D. ADULT B/VICTORIA/504/2000 ELDER (VACCINE USED IN 2001-02) 7. JOHN WOOD, PH.D ADULT B/JOHANNESBURG/5/99 (VACCINE USED IN 2001-02)

ANTIGENS FOR SEROLOGIES (H1): 

ANTIGENS FOR SEROLOGIES (H1) VACCINE STRAIN A/NEW CALEDONIA/20/99 (H1N1) REPRESENTATIVE CURRENT STRAINS A/DAKAR/85/2003 (H1N1) A/MINNESOTA/18/2003 (H1N1) A/NAGANO/1328/2003 (H1N1) A/BELEM/84066/03 (H1N2) A/ICELAND/123/2003 (H1N2) A/PERU/2223/2003 (H1N2) A/VIRGINIA/20/03 (H1N2)

HI ANTIBODY RESPONSES TO THE H1 COMPONENT 2003-2004 INFLUENZA VACCINE ADULT POPULATION (CDC): 

HI ANTIBODY RESPONSES TO THE H1 COMPONENT 2003-2004 INFLUENZA VACCINE ADULT POPULATION (CDC)

HI ANTIBODY RESPONSES TO THE H1 COMPONENT 2003-2004 INFLUENZA VACCINE ELDERLY POPULATION (NIBSC): 

HI ANTIBODY RESPONSES TO THE H1 COMPONENT 2003-2004 INFLUENZA VACCINE ELDERLY POPULATION (NIBSC)

HI ANTIBODY RESPONSES TO THE H1 COMPONENT 2003-2004 INFLUENZA VACCINE PEDIATRIC POPULATION (CDC AND CBER): 

HI ANTIBODY RESPONSES TO THE H1 COMPONENT 2003-2004 INFLUENZA VACCINE PEDIATRIC POPULATION (CDC AND CBER)

A/NEW CALEDONIA/20/99-LIKE VACCINES SUMMARY TABLE VIRUSES WITH > 50% GMT REDUCTION: 

A/NEW CALEDONIA/20/99-LIKE VACCINES SUMMARY TABLE VIRUSES WITH > 50% GMT REDUCTION

ANTIGENS FOR SEROLOGIES (H3): 

ANTIGENS FOR SEROLOGIES (H3) VACCINE STRAIN A/PANAMA/2007/99 REPRESENTATIVE CURRENT STRAINS A/CHILE/82660/2003 A/AICHI/205/2003* A/KUMAMOTO/102/2002* A/FUJIAN/445/2003* A/NAGASAKI/152/2003* * = FUJIAN/411-LIKE A/TEXAS/40/2003* A/TEXAS/141/2003* A/WYOMING/03/2003* A/HONG KONG/1186/2002*

HI ANTIBODY RESPONSES TO THE H3 COMPONENT 2003-2004 INFLUENZA VACCINE ADULT POPULATION ( AUS ): 

HI ANTIBODY RESPONSES TO THE H3 COMPONENT 2003-2004 INFLUENZA VACCINE ADULT POPULATION ( AUS )

HI ANTIBODY RESPONSES TO THE H3 COMPONENT 2003-2004 INFLUENZA VACCINE ELDERLY POPULATION (CDC): 

HI ANTIBODY RESPONSES TO THE H3 COMPONENT 2003-2004 INFLUENZA VACCINE ELDERLY POPULATION (CDC)

HI ANTIBODY RESPONSES TO THE H3 COMPONENT 2003-2004 INFLUENZA VACCINE PEDIATRIC POPULATION (CDC AND CBER): 

HI ANTIBODY RESPONSES TO THE H3 COMPONENT 2003-2004 INFLUENZA VACCINE PEDIATRIC POPULATION (CDC AND CBER)

A/PANAMA/2007/99-LIKE VACCINES SUMMARY TABLE VIRUSES WITH > 50% GMT REDUCTION: 

A/PANAMA/2007/99-LIKE VACCINES SUMMARY TABLE VIRUSES WITH > 50% GMT REDUCTION

ANTIGENS FOR SEROLOGIES (B): 

ANTIGENS FOR SEROLOGIES (B) VACCINE STRAIN CURRENT VACCINE OLDER VACCINE B/SHANGDONG/7/97+ B/JOHANNESBURG/5/99 B/HONG KONG/1434/2002+ B/VICTORIA/504/2000 REPRESENTATIVE CURRENT STRAINS B/SICHUAN/259/2003+ B/BADEN-WURTENBURG/26/2002* B/SHAHGHAI/361/2002* B/JIANGSU/10/2003* + = HONG KONG/330-LIKE B/JILIN/20/2003* * = SHANGHAI/361-LIKE B/MALAYSIA/879/2003* B/WASHINGTON/3/2003*

HI ANTIBODY RESPONSES TO THE B COMPONENT 2003-2004 INFLUENZA VACCINE ADULT POPULATION (NIBSC): 

HI ANTIBODY RESPONSES TO THE B COMPONENT 2003-2004 INFLUENZA VACCINE ADULT POPULATION (NIBSC)

HI ANTIBODY RESPONSES TO THE B COMPONENT 2003-2004 INFLUENZA VACCINE ELDERLY POPULATION (CDC): 

HI ANTIBODY RESPONSES TO THE B COMPONENT 2003-2004 INFLUENZA VACCINE ELDERLY POPULATION (CDC)

HI ANTIBODY RESPONSES TO THE B COMPONENT 2003-2004 INFLUENZA VACCINE PEDIATRIC POPULATION (CDC AND CBER): 

HI ANTIBODY RESPONSES TO THE B COMPONENT 2003-2004 INFLUENZA VACCINE PEDIATRIC POPULATION (CDC AND CBER)

HI ANTIBODY RESPONSES TO THE B COMPONENT 2001-2002 INFLUENZA VACCINE ADULT AND ELDERLY (NIBSC AND CBER): 

HI ANTIBODY RESPONSES TO THE B COMPONENT 2001-2002 INFLUENZA VACCINE ADULT AND ELDERLY (NIBSC AND CBER)

B/HONG KONG/330/2001-LIKE VACCINES SUMMARY TABLE VIRUSES WITH > 50% GMT REDUCTION: 

B/HONG KONG/330/2001-LIKE VACCINES SUMMARY TABLE VIRUSES WITH > 50% GMT REDUCTION

Influenza Vaccine Responses Summary: 

Influenza Vaccine Responses Summary Studies with sera collected after immunization with current vaccines show that: Representative influenza A (H1N1) and (H1N2) viruses are well-inhibited Many a/Fujian/411/2002 (H3N2)-like viruses are less well inhibited than the the vaccine strain B/Hong Kong/330/2001-like viruses are well inhibited but B/Shanghai/361/2002 and similar viruses are less well inhibited than the vaccine strains